NCT02685436View on ClinicalTrials.gov

Role of Pepsin Assay in Wheezy Infants

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions
Gastroesophageal Reflux Disease
Interventions
DRUG

Omeprazole and domperidone

wheezy infants with abnormal MII-pH or reflux esophagitis will be given omeprazol(10mg/once/day) and domperidone (0.2mg/kg/day t.d.s)

All Listed Sponsors
lead

Mansoura University Children Hospital

OTHER

NCT02685436 - Role of Pepsin Assay in Wheezy Infants | Biotech Hunter | Biotech Hunter